Previous 10 | Next 10 |
home / stock / cyto / cyto articles
Altamira Therapeutics Ltd (NASDAQ: CYTO) shares are trading lower by 50% to $0.20 Monday morning after the company recently made strategic moves by...
U.S. stocks traded mixed this morning, with the Dow Jones index gaining more than 20 points on Monday. Following the market opening Monday, the Dow...
Over the past twenty days of trading, Altamira Therapeutics Ltd. (NASDAQ: CYTO), from October 26, 2023 to November 22, 2023 there is a potential S...
U.S. stocks traded slightly higher toward the end of trading, with the Nasdaq Composite gaining around 30 points on Friday. The Dow trade...
Shares of Dolby Laboratories, Inc. (NYSE: DLB) fell during Friday’s session following weak guidance. Dolby Laboratories reported quarterly ea...
U.S. stocks traded mostly flat midway through trading on Friday. The Dow traded up 0.01% to 34,945.78 while the NASDAQ fell 0.03% to 14,109.53. The...
Altamira Therapeutics Ltd (NASDAQ: CYTO) entered into a binding agreement to sell a 51% stake in its subsidiary Altamira Medica AG to a Swiss ...
U.S. stocks traded slightly lower this morning, with the Nasdaq Composite falling around 30 points on Friday. Following the market opening Friday, ...
Gainers Benson Hill, Inc. (NYSE: BHIL) shares jumped 48.1% to $0.3740. Seres Therapeutics, Inc. (NASDAQ: MCRB) climbed 45.9% to $1.20. Seres Ther...
News, Short Squeeze, Breakout and More Instantly...
Altamira Therapeutics Ltd. Company Name:
CYTO Stock Symbol:
NASDAQ Market:
Altamira Therapeutics Ltd. Website:
Hamilton, Bermuda, July 19, 2024 (GLOBE NEWSWIRE) -- Study shows significant reduction in aorta dilation, delayed rupture and lower mortality in established animal model of abdominal aortic aneurysm Altamira’s SemaPhore™ nanoparticles delivering SOD2 mRNA successfully to...
AZZ Inc. (AZZ) is expected to report $1.31 for Q1 2025 Express Inc. (EXPRQ) is expected to report for Q1 2025 Aeon Co. Ltd. ADR (AONNY) is expected to report for Q1 2025 Altamira Therapeutics Ltd. (CYTO) is expected to report for Q1 2024 Bassett Furniture Industries Incorporated (...
Hamilton, Bermuda, June 20, 2024 (GLOBE NEWSWIRE) -- Independent review discusses evidence supporting the use of betahistine to alleviate residual dizziness following physical repositioning procedures in benign paroxysmal positional vertigo (BPPV) patients Betahistine is markete...